1Patel A,ADVANCE Collaborative Group.Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus(the ADVANCE trial):a randomised controlled trial[J].Lancet,2007,370(9590):829-840.
2Cooper-DeHoff RM,INVEST Investigators.Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients-findings from the International Verapamil SR/Trandolapril Study (INVEST)[J].Am Heart J,2006,151(5):1072-1079.
4Klonoff DC.Continous glucose monitoring:roadmap for 21st century diabetes therapy[J].Diabetes Care,2005,28(13):1231-1239.
5Hirsch IB.Glycemic variability:it is not just about HbA1c anymore![J].Diabetes Technol Ther,2005,7(8):780-783.
6McCall AL,Cox DJ,Crean J,et al.A novel analytical method for assessing glucose variability:using CGMS in type 1 diabetes mellitus[J].Diabetes Technol Ther,2006,8(7):644-653.
7Lindstrom J,Louheranta A,Mannelin M,et al.The Finnish Diabetes Prevention Study (DPS):Lifestyle intervention and 3-year results on diet and physical activity[J].Diabetes Care,2003,26(33):3230-3236.
